Status:
RECRUITING
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Bone Sarcomas
Financial Toxicity
Eligibility:
All Genders
Brief Summary
To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on partici...
Detailed Description
Measure the prevalence of financial toxicity and the severity of it in orthopaedic oncology patients undergoing surgical intervention using an objective, validated instrument. Secondary objectives inc...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified.
- Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.
- Exclusion Criteria
- • Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.
Exclusion
Key Trial Info
Start Date :
September 2 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 2 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07215611
Start Date
September 2 2025
End Date
October 2 2030
Last Update
October 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030